Paper
RSC Advances
0.60; (mprep. 233)/(mplit 233–240 ꢀC).6 IR (KBr) n: 3436, 3060,
4.6.6 5-(2-Chlorophenyl)-10H-spiro[diindeno[1,2-b:20,10-e]
pyridine-11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5f).
Dark red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.62; mp
281 ꢀC. IR (KBr) n: 3435, 3061, 2922, 1703, 1578, 1386, 1337,
1003 cmꢁ1; 1H NMR (400 MHz, DMSO-d6) d: 8.19 (m, 1H, ArH),
8.15 (m, 1H, ArH), 8.06 (m, 1H, ArH), 8.02 (m, 1H, ArH), 7.94 (m,
1H, ArH), 7.87 (m, 3H, ArH), 7.78 (m, 2H, ArH), 7.73 (m, 1H,
ArH), 7.62 (m, 1H, ArH), 7.54 (m, 1H, ArH), 7.27 (m, 1H, ArH),
7.18 (m, 1H, ArH), 7.12 (m, 1H, ArH), 7.05 (m, 1H, ArH), 6.94 (m,
1H, ArH), 5.59 (d, J ¼ 4.0 Hz, 2H, ArH) ppm. Anal. calcd for
1
2924, 1699, 1511, 1383, 1252, 1000 cmꢁ1; H NMR (400 MHz,
DMSO-d6) d: 8.23 (d, J ¼ 8.0 Hz, 1H, ArH), 8.18 (m, 2H, ArH),
7.99 (t, J ¼ 8.0 Hz, 2H, ArH), 7.87 (d, J ¼ 8.0 Hz, 1H, ArH), 7.78 (d,
J ¼ 8.0 Hz, 2H, ArH), 7.60 (t, J ¼ 4.0 Hz, 2H, ArH), 7.33 (m, 2H,
ArH), 7.22 (m, 4H, ArH), 7.09 (d, J ¼ 8.0 Hz, 2H, ArH), 5.97 (d, J ¼
4.0 Hz, 2H, ArH), 3.98 (s, 3H, OCH3) ppm. Anal. calcd for
C
40H23N3O3: C, 80.93; H, 3.91; N, 7.08. Found: C, 80.88; H,
3.86; N, 7.04.
4.6.2 5-(3-Chlorophenyl)-10H-spiro[diindeno[1,2-b:20,10-e]
pyridine-11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5b).
Dark red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.55; mp
284 ꢀC. IR (KBr) n: 3432, 3063, 2922, 1700, 1578, 1384, 1301,
C
39H20ClN3O2: C, 78.33; H, 3.37; N, 7.03. Found: C, 78.27; H,
3.29; N, 6.98.
4.6.7 5-Phenyl-10H-spiro[diindeno[1,2-b:20,10-e]pyridine-
11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5g). Dark red
solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.64; (mprep. 277
1
999 cmꢁ1; H NMR (400 MHz, DMSO-d6) d: 8.22 (d, J ¼ 8.0 Hz,
1H, ArH), 8.17 (d, J ¼ 4.0 Hz, 2H, ArH), 8.13 (t, J ¼ 8.0 Hz, 1H,
ArH), 8.02 (d, J ¼ 8.0 Hz, 2H, ArH), 7.86 (m, 3H, ArH), 7.77 (s, 1H,
ArH), 7.60 (d, J ¼ 4.0 Hz, 2H, ArH), 7.23 (m, 4H, ArH), 7.11 (d, J ¼
4.0 Hz, 2H, ArH), 5.60 (d, J ¼ 4.0 Hz, 2H, ArH) ppm; 13C NMR
(100 MHz, DMSO-d6): d 46.2, 113.4, 121.7, 122.1, 122.8, 124.7,
129.4, 129.6, 129.7, 129.8, 130.3, 130.9, 131.4, 132.4, 132.7,
132.9, 133.2, 136.5, 136.6, 137.4, 139.5, 141.5, 142.3, 151.9,
155.0, 156.6, 156.7, 190.1 ppm. Anal. calcd for C39H20ClN3O2: C,
78.33; H, 3.37; N, 7.03. Found: C, 78.28; H, 3.33; N, 6.96.
4.6.3 5-(4-Hydroxyphenyl)-10H-spiro[diindeno[1,2-b:20,10-e]
pyridine-11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5c).
Dark red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.51;
mp: 251 ꢀC. IR (KBr) n: 3431, 3041, 2938, 1728, 1568, 1382, 1335,
ꢀC)/(mplit > 280 C).6 IR (KBr) n: 3430, 3062, 2910, 1696, 1579,
ꢀ
1385, 1336, 999 cmꢁ1; 1H NMR (400 MHz, DMSO-d6) d: 8.88 (m,
3H, ArH), 8.05 (m, 3H, ArH), 7.92 (m, 2H, ArH), 7.83 (m, 3H,
ArH), 7.62 (m, 2H, ArH), 7.23 (m, 2H, ArH), 7.10 (m, 4H, ArH),
5.59 (d, J ¼ 8.0 Hz, 2H, ArH) ppm. Anal. calcd for C39H21N3O2: C,
83.11; H, 3.76; N, 7.46. Found: C, 83.07; H, 3.69; N, 7.38.
4.6.8 5-(o-Tolyl)-10H-spiro[diindeno[1,2-b:20,10-e]pyridine-
11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5h). Dark
red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.61; mp
201 ꢀC. IR (KBr) n: 3438, 3061, 2927, 1697, 1578, 1386, 1337,
1000 cmꢁ1; 1H NMR (400 MHz, DMSO-d6) d: 8.21 (m, 2H, ArH),
8.19 (m, 1H, ArH), 8.02 (m, 2H, ArH), 7.86 (m, 2H, ArH), 7.83 (m,
2H, ArH), 7.77 (m, 2H, ArH), 7.67 (m, 1H, ArH), 7.23 (m, 1H,
ArH), 7.21 (m, 1H, ArH), 7.15 (m, 1H, ArH), 7.12 (m, 1H, ArH),
6.96 (m, 1H, ArH), 6.88 (m, 1H, ArH), 5.55 (d, J ¼ 8.0 Hz, 2H,
ArH), 1.21 (s, 3H, CH3) ppm; 13C NMR (100 MHz, DMSO-d6) d:
17.7, 46.4, 121.9, 122.1, 122.8, 124.7, 128.6, 129.1, 129.5, 129.8,
130.3, 130.8, 130.0, 131.4, 132.1, 132.4, 132.9, 133.2, 133.3,
136.4, 136.8, 137.1, 137.4, 138.2, 141.5, 142.6, 151.9, 154.9,
156.8, 156.2, 190.1 ppm. Anal. calcd for C40H23N3O2: C, 83.17;
H, 4.01; N, 7.27. Found: C, 83.11; H, 3.96; N, 7.17.
1
1198 cmꢁ1; H NMR (400 MHz, DMSO-d6) d: 8.18 (s, 1H, ArH),
8.15 (s, 1H, ArH), 8.14 (s, 1H, ArH), 8.12 (s, J ¼ 8.0 Hz, 1H, ArH),
8.07 (s, 1H, ArH), 7.91 (s, 1H, ArH), 7.89 (s, 1H, ArH), 7.86 (s, 3H,
ArH), 7.72 (s, 1H, ArH), 7.70 (s, 1H, ArH), 7.68 (s, 1H, ArH), 7.30
(s, 1H, ArH), 7.29 (s, 1H, ArH), 7.25 (s, 1H, ArH), 7.21 (s, 1H,
ArH), 7.08 (s, 1H, OH), 5.71 (d, J ¼ 4.0 Hz, 2H, ArH) ppm. Anal.
calcd for C39H21N3O3: C, 80.82; H, 3.65; N, 7.25. Found: C, 80.75;
H, 3.60; N, 7.19.
4.6.4 5-(4-Chlorophenyl)-10H-spiro[diindeno[1,2-b:20,10-e]
pyridine-11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5d).
Dark red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.63; mp
289 ꢀC. IR (KBr) n: 3431, 3042, 2923, 1728, 1569, 1383, 1337,
1197 cmꢁ1; 1H NMR (400 MHz, DMSO-d6) d:1H NMR (400 MHz,
DMSO-d6): d (ppm) 8.18 (s, 1H, ArH), 8.15 (s, 1H, ArH), 8.14 (s,
1H, ArH), 8.12 (s, 1H, ArH), 8.09 (s, 2H, ArH), 7.95 (s, 1H, ArH),
7.89 (s, 3H, ArH), 7.87 (s, 2H, ArH), 7.70 (t, J ¼ 8.0 Hz, 2H, ArH),
7.22 (s, 1H, ArH), 7.20 (s, 1H, ArH), 7.10 (d, J ¼ 4.0 Hz, 3H, ArH),
5.65 (d, J ¼ 4.0 Hz, 2H, ArH) ppm. Anal. calcd for C39H20ClN3O2:
C, 78.33; H, 3.37; N, 7.03. Found: C, 78.26; H, 3.30; N, 6.98.
4.6.5 5-(3-Nitrophenyl)-10H-spiro[diindeno[1,2-b:20,10-e]
pyridine-11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5e).
Dark red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.58; mp
181 ꢀC. IR (KBr) n: 3439, 3067, 2911, 1701, 1535, 1383, 1343,
1000 cmꢁ1; 1H NMR (400 MHz, DMSO-d6) d: 8.24 (d, J ¼ 8.0 Hz,
2H, ArH), 8.18 (d, J ¼ 8.0 Hz, 1H, ArH), 8.11 (m, 3H, ArH), 7.88
(m, 3H, ArH), 7.63 (t, J ¼ 8.0 Hz, 3H, ArH), 7.24 (d, J ¼ 8.0 Hz,
2H, ArH), 7.14 (m, 4H, ArH), 5.97 (d, J ¼ 8.0 Hz, 2H, ArH) ppm.
Anal. calcd for C39H20N4O5: C, 75.00; H, 3.23; N, 8.97. Found: C,
74.95; H, 3.18; N, 8.91.
4.6.9 5-(2,4-Dimethylphenyl)-10H-spiro[diindeno[1,2-
b:20,10-e]pyridine-11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-
dione (5i). Dark red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v)
¼ 0.58; mp 234 ꢀC. IR (KBr) n: 3428, 3062, 2923, 1702, 1573,
1385, 1337, 999 cmꢁ1; 1H NMR (400 MHz, DMSO-d6) d: 8.18 (d, J
¼ 8.0 Hz, 1H, ArH), 8.15 (s, 1H, ArH), 8.13 (s, 2H, ArH), 8.01 (d, J
¼ 8.0 Hz, 1H, ArH), 7.92 (s, 2H, ArH), 7.89 (d, J ¼ 8.0 Hz, 2H,
ArH), 7.73 (d, J ¼ 8.0 Hz, 2H, ArH), 7.61 (s, 1H, ArH), 7.52 (s, 1H,
ArH), 7.46 (d, J ¼ 8.0 Hz, 1H, ArH), 7.22 (d, J ¼ 8.0 Hz, 2H, ArH),
7.16 (d, J ¼ 8.0 Hz, 1H, ArH), 7.08 (s, 2H, ArH), 5.63 (d, J ¼
4.0 Hz, 2H, ArH), 2.56 (s, 3H, CH3), 2.38 (s, 3H, CH3) ppm. Anal.
calcd for C41H25N3O2: C, 83.23; H, 4.26; N, 7.10. Found: C, 83.18;
H, 4.19; N, 7.01.
4.6.10 5-(4-Methylphenyl)-10H-spiro[diindeno[1,2-b:20,10-e]
pyridine-11,110-indeno[1,2-b]quinoxaline]-10,12(5H)-dione (5j).
Dark red solid, Rf (n-hexane : ethylacetate): 7 : 3 (v/v) ¼ 0.64;
(mprep. 197 ꢀC)/(mplit 193–205 ꢀC).6 IR (KBr) n: 3432, 3061, 2923,
1697, 1577, 1386, 1337, 997 cmꢁ1; 1H NMR (400 MHz, DMSO-d6)
d: 8.24 (s, 1H, ArH), 8.19 (d, J ¼ 8.0 Hz, 1H, ArH), 8.13 (s, 1H,
ArH), 8.05 (d, J ¼ 8.0 Hz, 3H, ArH), 7.92 (d, J ¼ 8.0 Hz, 1H, ArH),
This journal is © The Royal Society of Chemistry 2020
RSC Adv., 2020, 10, 33334–33343 | 33341